Terminology Service for NFDI4Health
Immunopotentiation
Go to external page
http://purl.obolibrary.org/obo/NCIT_C40912
An Immunopotentiation Effect involves stimulation of biologic molecules and complexes, or cellular, cell, or tissue components of a normal immune response. [ ]
Term info
Label
Immunopotentiation
Synonyms
- Immunopotentiation
Legacy Concept Name
Immunopotentiation_Effect
Preferred Name
Immunopotentiation
Semantic Type
Physiologic Function
UMLS CUI
C1512675
code
C40912
Term relations
Related from:
Chemical_Or_Drug_Has_Physiologic_Effect
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- Recombinant Interleukin-7
- Binetrakin
- hVEGF26-104/RFASE Peptide Vaccine
- Lorukafusp alfa
- Recombinant Vaccinia-Mgp100 Vaccine
- HPV 18 E6:13-21 Peptide
- Recombinant Interferon Beta
- hTERT-encoding DNA Vaccine INVAC-1
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- MAGE-A3-expressing Adenovirus Type 5 Vaccine
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
- Autologous Cytoplasmic Activated PD-1 CAR T-cells
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D
- UV1 Telomerase Peptide Vaccine
- Neoantigen-based Glioblastoma Vaccine
- Autologous IL-2-expressing B-CLL Vaccine
- Autologous CD40L-expressing B-CLL Vaccine
- Long Peptide Vaccine 7
- 2G-1 TCR Retroviral Vector-Transduced Lymphocytes
- Immunocytokine NHS-IL2-LT
- P53-Synthetic Long Peptides Vaccine
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous PBL
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous TIL
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte
- PR-151 Peptide
- ESO-1 Reactive Autologous Tumor Infiltrating Lymphocyte
- VHL-59: 116-128 Peptide
- VHL-42: 65-76(V74G) Peptide
- gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
- gp100-Reactive Autologous Peripheral Blood Lymphocyte
- SBIL-2 Transduced Autologous Tumor-Infiltrating Lymphocyte
- HPV 16 E6 (18-26) Peptide
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- Mesothelin-specific Chimeric Antigen Receptor-engineered Peripheral Blood Lymphocytes
- Liposomal MUC1/PET-lipid A Vaccine ONT-10
- HPV 16 E7:86-93 Peptide Vaccine
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells
- Fowlpox-PSA-TRICOM Vaccine
- Rilimogene Galvacirepvec
- Daromun
- Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201
- Immunocytokine NHS-IL12
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M
- HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
- mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901
- IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
- Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells
- Galinpepimut-S
- Alpha-type-1 Polarized Dendritic Cells
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
- Gag:267-274 Peptide Vaccine
- Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes
- Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300
- WT1 Analog Peptide Vaccine
- Monoclonal Antibody CC49-delta CH2
- Recombinant Vaccinia-TRICOM Vaccine
- Recombinant Fowlpox GM-CSF Vaccine Adjuvant
- Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- Recombinant Fowlpox-TRICOM Vaccine
- Recombinant Fowlpox-B7.1 Vaccine
- Ipilimumab
- Telomerase: 540-548 Peptide Vaccine
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
- Carcinoembryonic Antigen Peptide 1-6D
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
- PSA:154-163 Peptide
- PR6V10 (ras-12 Asp) Peptide
- PR-5V10 (ras-12 Val) Peptide
- PR7V10 (ras-12 Ala) Peptide
- pNGVL3-hIL12
- PR-54 (ras-13 Asp) Peptide
- PCLUS 6.1-18MN
- PCLUS 3-18MN
- MART-1 Fowlpox Vaccine
- Monoclonal Antibody 95-6-22
- MART-1 Adenovirus Vaccine
- MART-1:26-35(27L) Peptide Vaccine
- MART-1:27-35 Peptide Vaccine
- MART-1 Vaccinia Vaccine
- KLH-Lymphoma Ig Vaccine
- gp100:209-217 Peptide
- gp100:17-25 Peptide
- gp100:280-288 Peptide Vaccine
- gp100-Pulsed Peripheral Blood Mononuclear Cell
- gp100-Fowlpox Vaccine
- gp100:154-162 Peptide Vaccine
- gp100: ES209-217(210M) Peptide
- gp100 and GM-CSF DNA/Gold Vaccine
- Human gp100 Plasmid DNA Vaccine
- gp100 cDNA/Gold Complex
- ESO-1:157-165(165V) Peptide
- gp100 Adenovirus Vaccine
- Conjugated Monoclonal Antibody CC49
- ALVAC-CEA (VCP248)